Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 44,400 shares at $25.12 ($1.1M) on 2021-08-09, disclosed to the SEC on 2021-08-11.
Open-market sale of $1.1M NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.81 | 7,731 | $184K | 17.3% |
| 2 | $23.81 | 7,731 | $184K | 17.3% |
| 3 | $25.12 | 6,669 | $168K | 15.7% |
| 4 | $25.12 | 6,669 | $168K | 15.7% |
| 5 | $25.62 | 600 | $15K | 1.4% |
| 6 | $23.15 | 15,000 |
| $347K |
| 32.6% |
| Total | $24.01 avg | 44,400 | $1.1M | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-09-14 | $1.5M | — | Filing → |